Abstract
Rhesus monkeys (n = 4) were trained to discriminate d-amphetamine (AMPH; 0.67 or 1.33 mumol/kg i.v.) from saline in a two lever, food-reinforced drug discrimination paradigm. After acquisition of the discrimination (average, 127 sessions), the monkeys were tested with a series of compounds selected to characterize the neuronal mechanism(s) of the discrimination. AMPH (0.08-2.6 mumol/kg), cocaine (0.06-1.0 mumol/kg; n = 4), the dopamine (DA) uptake inhibitor bupropion (0.25-2.0 mumol/kg; n = 2) and the norepinephrine (NE) uptake inhibitor nisoxetine (1.0-16 mumol/kg; n = 4) produced dose-related increases in the percentage of responses that occurred on the AMPH-appropriate lever during test sessions in all monkeys tested. For all other drugs tested, individual differences in effects were noted. Compounds with primarily D2 DA receptor activity, including apomorphine (0.06-1.0 mumol/kg; n = 4), piribedil (0.25-8.0 mumol/kg; n = 4), bromocriptine (0.12-1.0 mumol/kg; n = 4) and propylbutyldopamine (0.25-4.0 mumol/kg; n = 3) occasioned AMPH-appropriate responding in one or two monkeys. The D1 agonist SKF 38393 (0.5-64 mumol/kg; n = 4) and pentobarbital (4.0-32 mumol/kg; n = 4) substituted for AMPH in only one monkey. In tests for antagonism, the D1 antagonist SCH 23390 (0.015-0.03 mumol/kg; n = 2) blocked completely the discriminative stimulus effects of AMPH in a dose-related manner.(ABSTRACT TRUNCATED AT 250 WORDS)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|